ArticleACS infectious diseases2018

7 H-Pyrrolo[2,3- d]pyrimidin-4-amine-Based Inhibitors of Calcium-Dependent Protein Kinase 1 Have Distinct Inhibitory and Oral Pharmacokinetic Characteristics Compared with 1 H-Pyrazolo[3,4- d]pyrimidin-4-amine-Based Inhibitors.

Rama S R Vidadala et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.